Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Roivant Sciences Ltd. (ROIV) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Common Share Purchase and Sale Agreement",
"Opinion of Conyers Dill & Pearman Limited"
08/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BASEL, Switzerland and LONDON and NEW YORK, August 17, 2023",
"Notice of Redemption Fair Market Value"
08/14/2023 8-K Quarterly results
Docs: "Roivant Reports Financial Results for the First Quarter Ended June 30, 2023, and Provides Business Update"
08/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BASEL, Switzerland and LONDON and NEW YORK and BOSTON, August 2, 2023",
"Notice of Redemption"
05/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "LONG BEACH, Calif., and BASEL, Switzerland, May 16, 2023"
04/04/2023 8-K Other Events  Interactive Data
03/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "LONG BEACH, Calif., and BASEL, Switzerland, March 15, 2023"
02/13/2023 8-K Quarterly results
02/07/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Roivant Sciences Ltd.",
"Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares February 2, 2023 at 9:15 PM EST"
02/01/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
01/04/2023 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
09/28/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn",
"Presentation"
09/21/2022 8-K Resignation/termination of a director
08/15/2022 8-K Quarterly results
06/28/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
03/30/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation",
"Presentation"
02/28/2022 8-K Quarterly results
02/14/2022 8-K Quarterly results
Docs: "Common Shares Purchase Agreement, between Roivant Sciences Ltd. and CF Principal Investments LLC",
"Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update"
11/15/2021 8-K Quarterly results
Docs: "FORM 8-K",
"Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update"
10/01/2021 8-K Quarterly results
09/28/2021 8-K Quarterly results
09/21/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy